Events and Barriers are opportunities to address potential failure points with targeted Therapy Support for patients and clinicians.


KEY EVENTS

Open All Events
Diagnosis
  • Disease progression
  • Failure of earlier line(s) of therapy
  • Recommendation of self-injectable therapy
Treatment Initiation
  • Patient decision to move forward
  • Reimbursement
  • Patient training to self-inject
  • First injection
Ongoing Treatment
  • Shipment (possibly cold-chain)
  • Onset of side effects (possible)
  • Onset of efficacy (possible)
  • Returning for monitoring visits
  • Ongoing data/evidence collection for payers

FOCUS AREA

Self-Injectable Therapies

A self-injectable therapy patient support program developed and deployed by HCS had a 16:1 ROI.

Events and Barriers are opportunities to address potential failure points with targeted Therapy Support for patients and clinicians.


KEY EVENTS

Open All Events
Diagnosis
  • Disease progression
  • Failure of earlier line(s) of therapy
  • Recommendation of self-injectable therapy
Treatment Initiation
  • Patient decision to move forward
  • Reimbursement
  • Patient training to self-inject
  • First injection
Ongoing Treatment
  • Shipment (possibly cold-chain)
  • Onset of side effects (possible)
  • Onset of efficacy (possible)
  • Returning for monitoring visits
  • Ongoing data/evidence collection for payers

BARRIER ANALYSIS

Open All Barriers
PATIENT
BARRIERS
Understanding condition/treatment

    Lack of self-efficacy in ability to follow injection therapy instructions

    Unclear risk-benefit and distress-benefit ratios

Financial/cost issues

    Cost burden of office visits and treatment

    Impact of disease and treatment on work

Medication logistics

    Logistics of filling prescriptions

    Storage/disposal of medication

Psychosocial/emotional issues

    Fear of infusions

    Fear, anxiety, and stigma about self-injecting

    Worry about disease progression and need for self-injectable

Clinician–patient relationship

    Loss of trust in provider due to previous treatment failure

    Lack of effective communication

Motivation/treatment fatigue

    Side effects such as injection site reaction

    Experiencing efficacy or lack of efficacy and doubting need for continued treatment

CLINICIAN
BARRIERS
Financial/cost issues

    Reimbursement process

    Possible need for prior authorization

Patient communication/expectation setting

    Limited time/resources to address psychosocial patient needs

    Difficulty explaining self-injection process

    Lack of confidence in patient’s ability to self-inject

    Identification/management of safety/side effects

Ongoing disease and treatment monitoring

    Patient returning for follow-up visits

    Data/evidence collection (eg, quality of life, efficacy measures) at and between follow-up patient visits

IMPACT

HCS
SOLUTION

A comprehensive program that engages patients to understand their condition and self-injectable therapies, set expectations, prepare and stay motivated for therapy, and overcome other barriers by working to:

  • Instill confidence in patients’ ability to manage self-injections
  • Connect patients with reimbursement services
  • Provide self-injection training
  • Coordinate shipment of (cold-chain) medication
  • Ensure patients attend scheduled visits
  • Support patients to manage side effects/other complexities of therapy
  • Provide inbound hotline for immediate patient support
  • Use provider portal to update clinicians on individual patients between visits